Cerclage for Singletons With Short Cervix Without Prior Preterm Birth

March 17, 2016 updated by: Gabriele Saccone, Federico II University

Cervical Cerclage for Singleton Gestations With Short Cervix and Without Prior Preterm Birth

Preterm birth remains the most common cause of perinatal morbidity and mortality. A short cervi- cal length on transvaginal ultrasonography has been shown to be one of the best predictors of preterm birth. In 2005 a meta-analysis by Berghella et al. showed that cervical cerclage does not prevent preterm birth (PTB) in women with short cervical lenght without prior PTB. However maybe the meta-analysis did not reach the statistical significance due to the small sample size

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Napoli, Italy, 80129
        • Recruiting
        • Gabriele Saccone

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Singleton pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 25 mm) on second trimester ultrasound at 18-23 6/7 weeks gestation
  • 18-50 years of age

Exclusion Criteria:

  • Multiple gestation
  • Prior spontaneous preterm birth 16-36 6/7 weeks
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Pessary in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound
  • Painful regular uterine contractions
  • Placenta previa

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cervical cerclage
Women randomized to receive cerclage should receive cervical cerclage Cerclage is a circumferential stitch of non-absorbable suture placed around the cervix
Cerclage is a circumferential stitch of non-absorbable suture placed around the cervix Cerclage type: McDonald Cerclage Suture: Permanent monofilament Pericerclage antibiotics: none Pericerclage tocolytics: none Bed rest: not recommended (in both groups)
NO_INTERVENTION: No intervention
No cerclage Women randomized to not receive cerclage represent the control arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Spontaneous preterm birth rates <34weeks
Time Frame: Less than 34 weeks gestation
Less than 34 weeks gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal death
Time Frame: Between birth and 28 days of age
Between birth and 28 days of age
Spontaneous preterm birth rates <37, <28 and <24 weeks
Time Frame: Less than 24, 28, and 37 weeks gestation
Less than 24, 28, and 37 weeks gestation
Type of delivery
Time Frame: Time of delivery
Cesarean delivery, Spontaneous vaginal delivery, operative vaginal delivery
Time of delivery
Spontaneous rupture of membranes
Time Frame: Less than 34 weeks gestation
Ruptured membranes <34 weeks
Less than 34 weeks gestation
birth weight
Time Frame: Time of delivery
Time of delivery
Chorioamnionitis
Time Frame: Time of delivery
histologic diagnosis of chorioamnionitis
Time of delivery
necrotizing enterocolitis
Time Frame: Between birth and 28 days of age
Between birth and 28 days of age
intraventricular hemorrhage
Time Frame: Between birth and 28 days of age
intraventricular hemorrhage (grade 3 or higher)
Between birth and 28 days of age
respiratory distress syndrome
Time Frame: Between birth and 28 days of age
Between birth and 28 days of age
bronchopulmonary dysplasia
Time Frame: Between birth and 28 days of age
Between birth and 28 days of age
blood-culture proven sepsis
Time Frame: Between birth and 28 days of age
Between birth and 28 days of age
neonatal mortality
Time Frame: Between birth and 28 days of age
death of a live-born baby within the first 28 days of life
Between birth and 28 days of age
perinatal death
Time Frame: Until 28 days of age
either fetal mortality or neonatal mortality
Until 28 days of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (ANTICIPATED)

April 1, 2018

Study Completion (ANTICIPATED)

March 1, 2019

Study Registration Dates

First Submitted

March 6, 2016

First Submitted That Met QC Criteria

March 17, 2016

First Posted (ESTIMATE)

March 23, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

March 23, 2016

Last Update Submitted That Met QC Criteria

March 17, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 33/2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Cervical cerclage

3
Subscribe